Lv41
490 积分 2026-10-14 加入
Benefits and Harms of Standard Versus Reduced‐Dose Direct Oral Anticoagulant Therapy for Older Adults With Multiple Morbidities and Atrial Fibrillation
20分钟前
已完结
Phenotype-Directed Clinically Driven Low-Dose Direct Oral Anticoagulant for Atrial Fibrillation
21分钟前
已关闭
Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study
25分钟前
已完结
Assessment of Non-Vitamin K Antagonist Oral Anticoagulant Dosing Patterns in Turkish Patients with Non-Valvular Atrial Fibrillation: A Multicenter, Cross-Sectional Study with Insights from the ASPECT-NOAC Study*
35分钟前
已完结
Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk
35分钟前
已完结
The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events
35分钟前
待确认
Long-Term Outcomes of Dose-Stratified Direct Oral Anticoagulants in Atrial Fibrillation-Results From the Alfred-AF Registry
37分钟前
求助中
Anticoagulant regimen for non-valvular atrial fibrillation in the elderly and frail population
42分钟前
已完结
皖公网安备34019202002308
